A carregar...
HOXA5 confers tamoxifen resistance via the PI3K/AKT signaling pathway in ER-positive breast cancer
Tamoxifen is a commonly used drug to treat estrogen receptor-positive patients with breast cancer. Despite the outstanding efficacy of tamoxifen, approximately one-third of patients develop resistance toward it, thereby presenting a therapeutic challenge. HOX genes may be involved in the acquisition...
Na minha lista:
| Publicado no: | J Cancer |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ivyspring International Publisher
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8210559/ https://ncbi.nlm.nih.gov/pubmed/34149926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.59740 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|